openPR Logo
Press release

Generic Injectables Market to Expand at a CAGR of 12.3% from 2021 to 2031

08-09-2022 09:08 AM CET | Health & Medicine

Press release from: Transparency Market Research

Generic Injectables Market: Introduction

According to the report, the global generic injectables market was valued at US$ 83.09 Bn in 2020 and is projected to expand at a CAGR of 12.3% from 2021 to 2031.

Generic injectables are becoming more popular in the medical field for treatment of various diseases such as cancer, diabetes, and cardiac. Key market players focus on manufacturing cost-effective generic injectables.

The global generic injectables market is anticipated to be driven by increase in number of elderly patients, prevalence of diseases, number of regulatory approvals, and demand for generic injectables.

Report Overview: https://www.transparencymarketresearch.com/generic-injectables-market.html

Asia Pacific held a major share of the global generic injectables market in 2020 due to presence of large number of key players, rise in demand for generic injectables, and increase in chronic diseases.

The generic injectables market in Asia Pacific is expected to expand at a high CAGR of 13.6% from 2021 to 2031, due to surge in the number of elderly patients and increase in approval from regulatory authorities

Advent of New Technology to Drive Market
The rise in the prevalence of various diseases such as cancer, diabetes, cardiac and others has fueled the demand for generic injectables.

Teva Pharmaceutical Industries announced the USFDA acceptance of its BLA for the proposed biosimilar Trastuzumab for review. The biosimilar (CT-P6) is being developed by Celltrion, Inc. and Teva together for the treatment of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer and metastatic gastric cancer.

Sun Pharma launched complete range of generic anti-epilepsy drugs. Brivaracetam has been approved by the Drug Controller General of India (DCGI) as an adjunctive therapy in treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42698

Sanofi announced the U.S. FDA approval of once-daily Soliqua 100/33 (insulin glargine & lixisenatide injection) 100 units/mL & 33 mcg/mL for the treatment of adults with type 2 diabetes inadequately controlled on basal insulin (less than 60 Units daily).

Pfizer, Inc. focuses on the development of biosimilar formulations in key therapeutic areas, owing to its potential to improve patient care by extending access to high quality, effective, targeted treatment for multiple serious and chronic diseases.

Sandoz announced the U.S. FDA approval and launch of Glatopa 40 mg/ml, which is a fully substitutable, AP-rated generic version of Copaxone (glatiramer acetate injection) 40 mg/ml.

Glatopa was developed as per a collaboration agreement between Momenta Pharmaceuticals, Inc. and Sandoz. It is produced in the U.S.

Large Molecule Injectables Dominated Generic Injectables Market

In terms of product type, the global generic injectables market can be bifurcated into large injectable molecules and small injectable molecules.

The large injectable molecules segment dominated the global generic injectables market in 2020, and the trend is projected to continue during the forecast period.

The increase in the demand for large injectable molecules such as monoclonal antibodies and insulin is expected to drive the segment over the next few years.

Request Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=42698

Oncology to Offer Growth Opportunities
Based on application, the global generic injectables market can be classified into oncology, infectious diseases, diabetes, cardiology, immunology, and others.

The oncology segment dominated the global generic injectables market in 2020, and the trend is projected to continue during the forecast period. The rise in prevalence of cancer is expected to drive the segment in the near future.

Vials to Lead Generic Injectables Market

In terms of container type, the global generic injectables market has been categorized into vials, premix, prefilled syringes, ampoules, and others. The vials segment accounted for a major share of the market in 2020. The segment is projected to register highest market attractiveness index by 2031.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=42698

Intravenous to be Preferred Route of Administration

In terms of route of administration, the global generic injectables market has been divided into intravenous, intramuscular, subcutaneous, and others. The intravenous segment held a major share of the global generic injectables market in 2020. Increase in the geriatric population, surge in focus on manufacturing of injectables, and rise in prevalence of chronic diseases across the globe are projected to propel the intravenous segment.

Asia Pacific to be Lucrative Market for Generic Injectables

In terms of region, the global generic injectables market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Asia Pacific is projected to account for a leading share of the global generic injectables market during the forecast period, owing to the increase in the number of patients suffering from chronic diseases in hospitals.

The rise in the number of approvals for new ANDA by FDA boosts the demand for generic injectables.

The generic injectables market in Asia Pacific is projected to grow at a rapid pace over the next few years. India, China, and South Korea are expected to be lucrative markets in the near future.

Ask References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=42698

Growth Strategies of Key Players

Key players operating in the global generic injectables market are AstraZeneca, Baxter International, Inc., Biocon, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Hikma Pharmaceuticals plc, Johnson & Johnson Services, Inc., Lupin Ltd., Merck KGaA, Mylan N.V., Novartis AG (Sandoz International GmbH), Pfizer, Inc., Piramal Pharma Solutions, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.

Generic Injectables Market, by Application

o Oncology
o Infectious Diseases
o Cardiology
o Diabetes
o Immunology
o Others

More Trending Reports by Transparency Market Research:

Nonalcoholic Steatohepatitis Therapeutics Market: https://www.transparencymarketresearch.com/nonalcoholic-steatohepatitis-market.html

Psoriasis Treatment Market: https://www.transparencymarketresearch.com/psoriasis-treatment-market.html

Life Science Reagents Market: https://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html

Liquid Filled Hard Capsules Market https://www.transparencymarketresearch.com/liquidfilled-hard-capsules-market.html

Antihypertensive Drugs Market:
https://www.transparencymarketresearch.com/antihypertensive-drugs-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Injectables Market to Expand at a CAGR of 12.3% from 2021 to 2031 here

News-ID: 2701005 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the